Related Experiment Videos
3T3 variants unable to bind epidermal growth factor cannot complement in co-culture
Biochemical and Biophysical Research Communications
|January 13, 1984
Summary
Researchers isolated a new cell variant, 3T3-ENR7, that cannot divide when exposed to epidermal growth factor (EGF). This variant, like others, fails to bind EGF, indicating a defect in the EGF receptor pathway.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Epidermal growth factor (EGF) is a potent mitogen that stimulates cell proliferation.
- EGF signaling is crucial for various cellular processes, including growth and differentiation.
- Mutant cell lines unresponsive to EGF provide valuable tools for dissecting the EGF signaling pathway.
Purpose of the Study:
- To isolate and characterize new variants of Swiss-Webster 3T3 cells that are non-proliferative in response to EGF.
- To investigate the molecular basis of EGF non-responsiveness in these variants.
- To determine if complementation occurs between different EGF non-responsive variants.
Main Methods:
- Isolation of EGF non-proliferative variants using the mitogen-colchicine selection technique.
- Binding assays using radio-labeled 125I-EGF to assess EGF receptor function.
- Co-culture experiments to test for complementation of mitogenic response.
Main Results:
- A novel EGF non-proliferative variant, 3T3-ENR7, was successfully isolated.
- 3T3-ENR7, similar to previously identified variants (3T3-NR6, 3T3-TNR2), exhibited a complete inability to bind 125I-EGF.
- Co-culture experiments did not restore EGF-induced proliferation, suggesting a common defect or non-complementing mutations.
Conclusions:
- The 3T3-ENR7 variant possesses a defect in EGF binding, likely within the EGF receptor.
- The inability to restore proliferation through co-culture suggests that these EGF non-responsive variants may share a common molecular defect or represent mutations in the same pathway.
- These findings contribute to understanding the critical role of EGF receptor binding in mediating EGF-induced mitogenesis.